Pharma Company Bags New Rs 44 Crore Order From United Nations International Children's Emergency Fund (UNICEF)
Pharma Company Bags New Rs 44 Crore Order From United Nations International Children's Emergency Fund (UNICEF)
The company has a market cap of over Rs 3,000 crore and the stock gave multibagger returns of 382 per cent from its 52-week low of Rs 112.35 per share.
The company has a market cap of over Rs 3,000 crore and the stock gave multibagger returns of 382 per cent from its 52-week low of Rs 112.35 per share.
Eugia Pharma receives USFDA Approval for Dasatinib Tablets
The company has a market cap of over Rs 70,000 crore and the stock is up by 23 per cent from its 52-week low of Rs 994.35 per share.
The company has a market cap of over Rs 70,000 crore and the stock is up by 23 per cent from its 52-week low of Rs 994.35 per share.
Pharmaceuticals Company Gets USFDA Approval For Phytonadione Injectable Emulsion
The stock gave multibagger returns of 190 per cent in 2 years and a whopping 500 per cent in 5 years.
The stock gave multibagger returns of 190 per cent in 2 years and a whopping 500 per cent in 5 years.
Kiran Mazumdar Shaw-Backed Pharma Company is Likely to Raise Funds by Way of Issue of Equity Shares
The company has been maintaining a healthy dividend payout of 18 per cent.
The company has a market cap of Rs 39,728 crore where Kiran Mazumdar Shaw (promoter of the company) holds a 40.36 per cent stake in the company.
Pharma Company Has Received Final Approval From United States Food and Drug Administration For Abbreviated New Drug Application
The company has a market cap of over Rs 1 lakh crore and the stock is up by 13 per cent from its 52-week low of Rs 1,310.05 per share.
The company has a market cap of over Rs 1 lakh crore and the stock is up by 13 per cent from its 52-week low of Rs 1,310.05 per share.
Pharma Penny Stock Under Rs 60: Company Set For Bold Expansion; To Add 1000 Medical Representatives
The company has a market cap of over Rs 2,750 crore and the stock is up over 20 per cent from its 52-week low of Rs 41.66 per share
The company has a market cap of over Rs 2,750 crore and the stock is up over 20 per cent from its 52-week low of Rs 41.66 per share
Pharma Company Bags Order Worth Rs 150-180 Million From Tamil Nadu Medical Services Corporation
The company has a market cap of over Rs 300 crore and the stock is up by 1.6 per cent from its 52-week low of Rs 635 per share.
The company has a market cap of over Rs 300 crore and the stock is up by 1.6 per cent from its 52-week low of Rs 635 per share.
Pharma Company Expands Capabilities with New Peptide Research Center
The company's Price-Earnings (PE) Ratio stands at 165.54.
Major public shareholders include Tpg Asia Vii Sf Pte Ltd with 24.78 per cent, HBM Private Equity India with 1.99 per cent, Anitha Rudraraju Nandyala with 1.73 per cent, Raju Penmasta with 1.11 per cent and Penmasta Aruna with 1.02 per cent.
Pharma Company Enters Into Share Purchase Agreement and Power Supply Agreement with Torrent Urja 19 Pvt Ltd
The company has a market cap of over Rs 13,000 crore and the stock is up 45 per cent from its 52-week low of Rs 743.60 per share.
The company has a market cap of over Rs 13,000 crore and the stock is up 45 per cent from its 52-week low of Rs 743.60 per share.
Pharma Penny Stock Under Rs 50 Jumps Over 5 Per Cent on April 03; Do you Have It?
From Rs 34 per share (52-week low) to Rs 38.90 per share, the stock is up by 14.4 per cent.
From Rs 34 per share (52-week low) to Rs 38.90 per share, the stock is up by 14.4 per cent.
46 Per Cent Returns From 52-Week Low: Pharma Stock Under Rs 75, Hit 10 Per Cent Upper Circuit; Here’s Why
The company has a market cap of over Rs 400 crore and the stock is up by 46 per cent from its 52-week low of Rs 50.42 per share.
The company has a market cap of over Rs 400 crore and the stock is up by 46 per cent from its 52-week low of Rs 50.42 per share.
Multibagger Pharma Company Expands into New Territory with Innovative Pediatric Solution
The stock has delivered 85 per cent in 1 year and gave multibagger returns of 240 per cent in 2 years.
The stock has delivered 85 per cent in 1 year and gave multibagger returns of 240 per cent in 2 years.